|
A-431
|
IC50 |
|
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
A-431
|
IC50 |
|
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
A-431
|
IC50 |
|
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
Cytotoxic activity against human A431 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
A-431
|
IC50 |
|
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
A-431
|
IC50 |
|
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
Cytotoxic activity against human A431 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
A549
|
IC50 |
|
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
A549
|
IC50 |
|
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
A549
|
IC50 |
|
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
Cytotoxic activity against human A549 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
PC-12
|
IC50 |
|
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
|
[PMID: 19845386]
|
|
A549
|
IC50 |
|
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
CHO
|
EC50 |
|
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
|
[PMID: 18307294]
|
|
A549
|
IC50 |
|
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
Cytotoxic activity against human A549 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
A549
|
IC50 |
|
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
CHO
|
EC50 |
|
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
|
[PMID: 18307294]
|
|
PC-12
|
IC50 |
|
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
|
[PMID: 19845386]
|
|
DU-145
|
IC50 |
|
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
DU-145
|
IC50 |
|
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HCT-116
|
IC50 |
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HCT-116
|
IC50 |
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HEK293
|
EC50 |
|
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
|
[PMID: 24928400]
|
|
HEK293
|
EC50 |
|
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
|
[PMID: 24928400]
|
|
CHO
|
EC50 |
|
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
Agonist activity at human TGR5 expressed in CHO cells by luciferase assay
|
[PMID: 18307294]
|
|
HEK-293T
|
IC50 |
24.9 3
Compound: 1, DHEA, dehydroepiandrosterone
|
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
|
[PMID: 22506561]
|
|
HEK-293T
|
IC50 |
24.9 3
Compound: 1, DHEA, dehydroepiandrosterone
|
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
|
[PMID: 22506561]
|
|
HeLa
|
IC50 |
|
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
HeLa
|
IC50 |
|
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
HepG2
|
IC50 |
|
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
HeLa
|
IC50 |
|
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
DU-145
|
IC50 |
|
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human DU145 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HCT-116
|
IC50 |
|
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT116 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HepG2
|
IC50 |
|
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
|
[PMID: 26866967]
|
|
HEK-293T
|
IC50 |
24.9 3
Compound: 1, DHEA, dehydroepiandrosterone
|
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
Inhibition of G6PD in HEK293T cells assessed as accumulation of 6-phosphogluconate after 5 hrs by LC-MS/MS analysis using 6-aminonicotinamide
|
[PMID: 22506561]
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
HepG2
|
IC50 |
|
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
HEK293
|
EC50 |
|
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
Binding affinity to FLAG/tGFP-tagged NPC1 I1061T mutant (unknown origin) expressed in HEK293 cells assessed as localization after 24 hrs by fluorescence microscopy
|
[PMID: 24928400]
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
HT-29
|
IC50 |
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HT-29
|
IC50 |
|
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
|
[PMID: 26866967]
|
|
J774.2
|
CC50 |
198.17 3
Compound: 1a; DHEA
|
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
|
[PMID: 34571489]
|
|
HT-29
|
IC50 |
|
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
HT-29
|
IC50 |
|
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
Jurkat
|
IC50 |
|
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
|
[PMID: 26866967]
|
|
LNCaP
|
IC50 |
|
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HL-60
|
IC50 |
|
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human HL60 cells assessed as reduction in cell viability after 96 hrs by MTS assay
|
[PMID: 26866967]
|
|
HT-29
|
IC50 |
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HT-29
|
IC50 |
|
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
J774.2
|
CC50 |
198.17 3
Compound: 1a; DHEA
|
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
|
[PMID: 34571489]
|
|
LNCaP
|
IC50 |
|
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
HT-29
|
IC50 |
|
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
Cytotoxic activity against human HT-29 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
Jurkat
|
IC50 |
|
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
|
[PMID: 26866967]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HT-29
|
IC50 |
|
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
LNCaP
|
IC50 |
|
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
HeLa
|
IC50 |
|
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
LNCaP
|
IC50 |
|
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
MCF7
|
IC50 |
|
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23880359]
|
|
HeLa
|
IC50 |
|
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
Cytotoxic activity against human HeLa cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
LNCaP
|
IC50 |
|
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
HepG2
|
IC50 |
|
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
HepG2
|
IC50 |
|
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
Cytotoxic activity against human HepG2 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23880359]
|
|
J774.A1
|
IC50 |
|
Inhibition of LPS-induced TNFalpha production in mouse J774A.1 cells
Inhibition of LPS-induced TNFalpha production in mouse J774A.1 cells
|
[PMID: 17892941]
|
|
J774.2
|
CC50 |
198.17 3
Compound: 1a; DHEA
|
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
Cytotoxicity against mouse J774.2 cells assessed as reduction in cell viability measured after 48 hrs by resazurin dye based assay
|
[PMID: 34571489]
|
|
SMMC-7721
|
IC50 |
|
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
MCF7
|
IC50 |
|
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
J774.A1
|
IC50 |
|
Inhibition of LPS-induced TNFalpha production in mouse J774A.1 cells
Inhibition of LPS-induced TNFalpha production in mouse J774A.1 cells
|
[PMID: 17892941]
|
|
SW480
|
IC50 |
|
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
MCF7
|
IC50 |
|
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
Jurkat
|
IC50 |
|
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
Antiproliferative activity against human Jurkat cells assessed as reduction in cell viability after 96 hrs by MTS assay
|
[PMID: 26866967]
|
|
T47D
|
IC50 |
|
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
LNCaP
|
IC50 |
|
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
LNCaP
|
IC50 |
|
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
Cytotoxic activity against human LNCAP cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
PC-12
|
IC50 |
|
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
|
[PMID: 19845386]
|
|
PC-12
|
IC50 |
|
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
|
[PMID: 19845386]
|
|
LNCaP
|
IC50 |
|
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human LNCAP cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
SMMC-7721
|
IC50 |
|
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
MCF7
|
IC50 |
|
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxicity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 23880359]
|
|
SW480
|
IC50 |
|
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
MCF7
|
IC50 |
|
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 24 hrs by MTT assay
|
[PMID: 25456391]
|
|
T47D
|
IC50 |
|
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
MCF7
|
IC50 |
|
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
Cytotoxic activity against human MCF7 cells after 48 hrs by MTT assay
|
[PMID: 25456391]
|
|
MCF7
|
IC50 |
|
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
MDA-MB-231
|
IC50 |
|
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human MDA-MB-231 cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|
|
PC-12
|
IC50 |
|
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
Neuroprotective activity in rat PC12 cells assessed as inhibition of serum deprivation-induced apoptosis after 24 hrs by APO Percentage apoptosis assay
|
[PMID: 19845386]
|
|
PC-12
|
IC50 |
|
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
Displacement of [3H]DHEA from DHEA-binding site in rat PC12 cell membranes by gamma-scintillation counting
|
[PMID: 19845386]
|
|
SMMC-7721
|
IC50 |
|
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SMMC7721 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
SW480
|
IC50 |
|
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
Antiproliferative activity against human SW480 cells assessed as reduction in cell viability incubated for 48 hrs by MTS assay
|
[PMID: 30822712]
|
|
T47D
|
IC50 |
|
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
Antiproliferative activity against human T47D cells assessed as reduction in cell viability after 96 hrs by sulforhodamine B assay
|
[PMID: 26866967]
|